CZM own the Trademark "Convivo" as an "Optical approach to visualize in vivo cellular structure for medical use; endomicroscope for medical use". The device was demonstrated on April 23, 2017 via satellite symposium entitled "Advanced Use of Computer Based Simulation Technologies for Intracranial Surgery". This doesn't appear to relate to CZM Kinevo 900 nor QEVO but I understand more will be revealed at the Boston meeting about the CZM product incorporating Optiscan technology.
Following the $3.5m raising I think the share price has strong support.
Add to My Watchlist
What is My Watchlist?
